School of Pharmacy , The Chinese University of Hong Kong , Sha Tin , Hong Kong.
Department of Pharmacology and Pharmacy , The University of Hong Kong , Pokfulam , Hong Kong.
Mol Pharm. 2019 Jan 7;16(1):195-204. doi: 10.1021/acs.molpharmaceut.8b00945. Epub 2018 Dec 19.
While flash nanoprecipitation (FNP) has proven to be an extremely rapid and highly efficient nanoparticle fabrication process for hydrophobic drugs, physical instability associated with nonequilibrium molecular orientation of amphiphilic stabilizers (ASs) in nanoparticles remains a major snag in the general application of this nanotechnology, particularly for a drug with ACDLog P in the range of ∼2-9. This study was aimed at elucidating the costabilizing role of cholesterol (CLT) in the FNP of AS-stabilized nanoparticles of itraconazole (ITZ), a model drug with an ACDLog P of 4.35 ± 1.22 and log P of 5.66. The presence of CLT was shown to reduce the initial particle size and markedly improve the short-term storage stability of ITZ nanoparticles. The stability-enhancement by CLT can be linked to its higher miscibility or stronger interaction with the AS hydrophobic moiety than with ITZ (as reflected by the absolute differences of their solubility parameter values). Surface analyses employing X-ray photoelectron spectroscopy (XPS) and atomic force microscopy (AFM) suggest that, through the coprecipitation of CLT with ITZ to form a mixed hydrophobic drug core, the CLT molecules that are exposed on the core surface serve to afford a stronger and more timely surface anchorage of the AS hydrophobic moieties, thereby facilitating the rearrangement of AS molecules toward the stable micelle-like structure. The present findings offer a mechanistic insight into the interplay between amphiphilic stabilizer and costabilizer in enhancing the physical stability of drug nanoparticles and may carry important implications for the development of more stable and efficacious nanoparticle therapeutics.
虽然闪光纳米沉淀(FNP)已被证明是一种非常快速且高效的纳米颗粒制造工艺,可用于疏水性药物,但与两亲稳定剂(AS)在纳米颗粒中分子非平衡取向相关的物理不稳定性仍然是该纳米技术广泛应用的主要障碍,特别是对于 ACDLog P 在 2-9 范围内的药物。本研究旨在阐明胆固醇(CLT)在 FNP 中作为模型药物伊曲康唑(ITZ)的 AS 稳定纳米颗粒的共稳定作用,ITZ 的 ACDLog P 为 4.35±1.22,log P 为 5.66。结果表明,CLT 的存在可以减小初始颗粒尺寸并显著改善 ITZ 纳米颗粒的短期储存稳定性。CLT 的稳定性增强可归因于其与 AS 疏水性部分的更高混溶性或更强相互作用,而不是与 ITZ(如溶解度参数值的绝对值差异所反映的那样)。使用 X 射线光电子能谱(XPS)和原子力显微镜(AFM)进行的表面分析表明,通过 CLT 与 ITZ 的共沉淀形成混合疏水性药物核,暴露在核表面上的 CLT 分子有助于 AS 疏水性部分更牢固和更及时地进行表面锚定,从而促进 AS 分子向稳定的胶束样结构进行重排。本研究结果提供了一种机制见解,了解了两亲稳定剂和共稳定剂在增强药物纳米颗粒物理稳定性方面的相互作用,对于开发更稳定和有效的纳米粒治疗药物可能具有重要意义。